Skip to main content
TipRanks
Go Ultimate75% OFF

Corcept Therapeutics (0I3Q) Ownership - Who Owns Corcept Therapeutics?

2 Followers

Corcept Therapeutics (0I3Q) Ownership Overview

  • 10.53% Insiders
  • 15.68% Mutual Funds
  • 25.05% Other Institutional Investors
  • 19.03% ETFs
  • 29.72% Public Companies and Individual Investors

The ownership structure of Corcept Therapeutics (GB:0I3Q) stock is a mix of institutional, retail, and individual investors. Approximately 59.76% of the company’s stock is owned by Institutional Investors, 10.53% is owned by Insiders, and 29.72% is owned by Public Companies and Individual Investors.

Institutional holdings as of (latest 13F reporting period).

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Aug 27, 2026Park Kimberly$3,269,980
Aug 17, 2026Gary Charles Robb$1,162,500
Aug 04, 2026Joseph Douglas Lyon$175,806
Jun 17, 2026David L. Mahoney$1,690,400

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Dec 31, 2025Royce & Associates Llc$5,796,357
Dec 31, 2025Bridgewater Associates, Lp$9,709,200

Top Shareholders

GB:0I3Q top shareholders
Holder# of SharesType% HoldingValue
BlackRock, Inc.10,195,060Institution9.32%706,007,905
Vanguard8,445,620Institution7.72%584,859,185
Vanguard Index Funds7,289,126Institution6.66%504,771,976
Ishares6,392,135Institution5.84%442,655,349
Leonard G. Baker5,550,196Insider5.07%384,351,073
Joseph Belanoff2,865,489Insider2.62%198,435,113
Spdr2,037,350Institution1.86%141,086,488
Fidelity Contrafund1,599,462Institution1.46%110,762,744
James N. Wilson1,454,543Insider1.33%100,727,103
First Trust1,195,728Institution1.09%82,804,164

Top Mutual Fund Holders

GB:0I3Q top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds7,289,126Institution6.66%504,771,976
Fidelity Contrafund1,599,462Institution1.46%110,762,744
Fidelity Concord Street Trust953,156Institution0.87%66,006,053
Vanguard Tax-managed Funds666,455Institution0.61%46,152,009
Fidelity Salem Street Trust612,511Institution0.56%42,416,387
Fidelity Select Portfolios551,746Institution0.50%38,208,411
Fidelity Rutland Square Trust Ii543,395Institution0.50%37,630,104
Capitol Series Trust470,000Institution0.43%32,547,500
Dfa Investment Dimensions Group Inc454,280Institution0.42%31,458,890
Tiaa-cref Funds414,496Institution0.38%28,703,848

FAQ

Who Owns Corcept Therapeutics (GB:0I3Q)?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 59.76% of the company's stock is held by institutional investors, 10.53% is held by insiders, and 29.72% is held by public companies and individual investors.
What percentage of Corcept Therapeutics (GB:0I3Q) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 59.76% of Corcept Therapeutics (GB:0I3Q) stock is held by institutional investors: 15.68% by mutual funds, 19.03% by ETFs and 25.05% by other institutional investors.
What percentage of Corcept Therapeutics (GB:0I3Q) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of December 31, 2025), approximately 29.72% of Corcept Therapeutics (GB:0I3Q) stock is held by public companies and individual investors.
Who owns the most shares of Corcept Therapeutics (GB:0I3Q)?
BlackRock, Inc. owns the most shares of Corcept Therapeutics (GB:0I3Q).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.